Page last updated: 2024-08-21

eosine yellowish-(ys) and Idiopathic Inflammatory Myopathies

eosine yellowish-(ys) has been researched along with Idiopathic Inflammatory Myopathies in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Aguilar-Vazquez, A; Armendariz-Borunda, J; Chavarria-Avila, E; Duran-Barragan, S; Godínez-Rubí, M; Gómez-Limón, L; Gomez-Rios, CA; Llamas-Garcia, A; Lozano-Torres, Y; Lundberg, I; Martin-Marquez, BT; Martinez-Garcia, EA; Medina-Preciado, JD; Palacios-Zárate, BL; Pizano-Martinez, O; Rodríguez-Baeza, M; Salazar-Paramo, M; Sandoval-Rodriguez, A; Toriz-González, G; Vazquez-Del Mercado, M; Villanueva-Pérez, A1

Other Studies

1 other study(ies) available for eosine yellowish-(ys) and Idiopathic Inflammatory Myopathies

ArticleYear
Impaired muscle strength is associated with ultrastructure damage in myositis.
    Scientific reports, 2022, 10-21, Volume: 12, Issue:1

    Topics: Autoantibodies; Eosine Yellowish-(YS); Hematoxylin; Humans; Interleukin-10; Interleukin-17; Interleukin-18; Interleukin-23; Interleukin-33; Interleukin-6; Muscle Strength; Myositis; Tumor Necrosis Factor-alpha

2022